ATE136219T1 - Kontrazeptionsverfahren und schema - Google Patents

Kontrazeptionsverfahren und schema

Info

Publication number: ATE136219T1
Authority: AT; Austria
Prior art keywords: progestogen; dosage units; equivalent; contraceptive; dosage
Prior art date: 1990-12-17

Application number

AT91203282T

Other languages

English (en)

Inventor

Bennink Herman Jan Ti Coelingh

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-17

Filing date

1991-12-12

Publication date

1996-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE136219(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-12-12 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

1996-04-15 Application granted granted Critical

1996-04-15 Publication of ATE136219T1 publication Critical patent/ATE136219T1/de

Links

239000000583 progesterone congener Substances 0.000 abstract 6
239000003433 contraceptive agent Substances 0.000 abstract 4
BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 3
BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 3
230000002254 contraceptive effect Effects 0.000 abstract 3
RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 abstract 3
229960004976 desogestrel Drugs 0.000 abstract 3
239000000262 estrogen Substances 0.000 abstract 3
229940011871 estrogen Drugs 0.000 abstract 3
229960002568 ethinylestradiol Drugs 0.000 abstract 3
230000001076 estrogenic effect Effects 0.000 abstract 1
230000000757 progestagenic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Supplying Of Containers To The Packaging Station (AREA)
Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Treatment Of Sludge (AREA)
Seeds, Soups, And Other Foods (AREA)
Medicinal Preparation (AREA)

AT91203282T 1990-12-17 1991-12-12 Kontrazeptionsverfahren und schema ATE136219T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP90203372		1990-12-17

Publications (1)

Publication Number	Publication Date
ATE136219T1 true ATE136219T1 (de)	1996-04-15

Family

ID=8205204

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91203282T ATE136219T1 (de)	1990-12-17	1991-12-12	Kontrazeptionsverfahren und schema

Country Status (18)

Country	Link
US (1)	US5418228A (de)
EP (1)	EP0491438B1 (de)
JP (1)	JPH04290830A (de)
KR (1)	KR100186780B1 (de)
CN (1)	CN1036833C (de)
AT (1)	ATE136219T1 (de)
AU (1)	AU645637B2 (de)
CA (1)	CA2057747C (de)
DE (1)	DE69118494T2 (de)
DK (1)	DK0491438T3 (de)
ES (1)	ES2087965T3 (de)
FI (1)	FI98985C (de)
GR (1)	GR3020181T3 (de)
IE (1)	IE62665B1 (de)
NO (1)	NO179311C (de)
NZ (1)	NZ240970A (de)
PT (1)	PT99819B (de)
ZA (1)	ZA919770B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4227989A1 (de) *	1992-08-21	1994-06-09	Schering Ag	Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
US6407082B1 (en) *	1996-09-13	2002-06-18	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a vitamin D compound
DE4344462C2 (de)	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
EP0782449B1 (de) *	1994-09-22	2003-04-09	Akzo Nobel N.V.	Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
CA2159419C (en) *	1994-10-17	2006-07-04	Pieter De Haan	Solid pharmaceutical composition comprising an excipient capable of binding water
DE19540253C2 (de) *	1995-10-28	1998-06-04	Jenapharm Gmbh	Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
AU2926897A (en) *	1996-05-08	1997-11-26	American Home Products Corporation	Oral contraceptive
US5747480A (en) *	1996-05-08	1998-05-05	American Home Products Corporation	Oral contraceptive
US6479475B1 (en)	1996-07-26	2002-11-12	Wyeth	Oral contraceptive
US5858405A (en) *	1996-07-26	1999-01-12	American Home Products Corporation	Oral contraceptive
US6451778B1 (en)	1996-07-26	2002-09-17	Wyeth	Oral contraceptive
US5888543A (en) *	1996-07-26	1999-03-30	American Home Products Corporation	Oral contraceptives
AU713016B2 (en) *	1996-07-26	1999-11-18	Wyeth	Oral contraceptive
WO1998004267A1 (en) *	1996-07-26	1998-02-05	American Home Products Corporation	Progestin/estrogen oral contraceptive
US6028064A (en)	1996-09-13	2000-02-22	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of progestin products
US6034074A (en)	1996-09-13	2000-03-07	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en)	2000-03-21	2004-07-20	Gustavo Rodriguez	Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en) *	1996-09-13	2003-01-28	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
WO2001030355A1 (fr)	1999-10-25	2001-05-03	Laboratoire Theramex	Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr)	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
DE19739916C2 (de) *	1997-09-11	2001-09-13	Hesch Rolf Dieter	Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6028057A (en) *	1998-02-19	2000-02-22	Thorn Bioscience, Llc	Regulation of estrus and ovulation in gilts
US6214815B1 (en) *	1998-12-23	2001-04-10	Ortho-Mcneil Pharmaceuticals, Inc.	Triphasic oral contraceptive
US6660726B2 (en)	2000-03-10	2003-12-09	Endeavor Pharmaceuticals	Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) *	2000-03-10	2008-12-02	Duramed Pharmaceuticals, Inc.	Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) *	2003-07-23	2011-08-02	Duramed Pharmaceuticals, Inc.	Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en)	2000-03-10	2005-02-15	Endeavor Pharmaceuticals	Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20050113351A1 (en) *	2000-03-21	2005-05-26	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) *	2000-03-21	2001-11-22	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) *	2000-03-21	2004-09-09	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US7297688B2 (en)	2000-06-08	2007-11-20	Wyeth	Starter kit for low dose oral contraceptives
JP2004140323A (ja) *	2002-08-20	2004-05-13	Sharp Corp	半導体レーザ装置およびその製造方法
US6992075B2 (en) *	2003-04-04	2006-01-31	Barr Laboratories, Inc.	C(14) estrogenic compounds
MXPA05010871A (es) *	2003-04-11	2005-11-25	Barr Lab Inc	Metodos para administrar estrogenos y progestinas.
US7589082B2 (en) *	2003-06-13	2009-09-15	Skendi Finance Ltd	Pharmaceutical formulation for contraception and hormone-replacement therapy
AU2004277998A1 (en) *	2003-10-01	2005-04-14	Janssen Pharmaceutica N.V.	Extended triphasic contraceptive regimens
CA2540838C (en)	2003-10-03	2014-12-16	Thorn Bioscience, Llc	Process for the synchronization of ovulation for timed breeding without heat detection
WO2006084082A1 (en) *	2005-02-03	2006-08-10	Duramed Pharmaceuticals, Inc.	Compositions of unconjugated estrogens and methods for their use
US20070197435A1 (en) *	2006-02-17	2007-08-23	Webel Stephen K	Process for the synchronization of ovulation for timed breeding without heat detection
EP2343979B1 (de)	2008-10-08	2020-04-08	Agile Therapeutics, Inc.	Transdermale verabreichung
WO2010042607A1 (en)	2008-10-08	2010-04-15	Agile Therapeutics, Inc	Transdermal delivery
US9192614B2 (en)	2008-10-08	2015-11-24	Agile Therapeutics, Inc.	Contraceptive transdermal delivery of hormones
WO2010111488A1 (en)	2009-03-27	2010-09-30	Agile Therapeutics, Inc.	Transdermal delivery
ES2661240T3 (es)	2009-04-23	2018-03-28	Jbs United Animal Health Ii Llc	Método y composición para sincronizar el momento de inseminación
WO2014085674A1 (en)	2012-11-28	2014-06-05	Jbs United Animal Health Ii Llc	Method for synchronizing time of insemination in gilts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8001593A (nl) *	1980-03-18	1981-10-16	Akzo Nv	Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4530839A (en) *	1983-09-26	1985-07-23	Ortho Pharmaceutical Corporation	Triphasic oral contraceptive
US4962098A (en) *	1987-06-15	1990-10-09	Warner-Lambert Company	Graduated estrogen contraceptive
DK174724B1 (da) *	1986-07-15	2003-10-06	Wyeth Corp	Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet

1991
- 1991-12-09 IE IE427291A patent/IE62665B1/en not_active IP Right Cessation
- 1991-12-11 ZA ZA919770A patent/ZA919770B/xx unknown
- 1991-12-12 EP EP91203282A patent/EP0491438B1/de not_active Expired - Lifetime
- 1991-12-12 AT AT91203282T patent/ATE136219T1/de not_active IP Right Cessation
- 1991-12-12 DE DE69118494T patent/DE69118494T2/de not_active Expired - Fee Related
- 1991-12-12 ES ES91203282T patent/ES2087965T3/es not_active Expired - Lifetime
- 1991-12-12 DK DK91203282.8T patent/DK0491438T3/da active
- 1991-12-13 AU AU89679/91A patent/AU645637B2/en not_active Ceased
- 1991-12-13 NZ NZ240970A patent/NZ240970A/en not_active IP Right Cessation
- 1991-12-16 NO NO914969A patent/NO179311C/no unknown
- 1991-12-16 KR KR1019910023067A patent/KR100186780B1/ko not_active Expired - Fee Related
- 1991-12-16 PT PT99819A patent/PT99819B/pt not_active IP Right Cessation
- 1991-12-16 FI FI915914A patent/FI98985C/fi not_active IP Right Cessation
- 1991-12-16 CA CA002057747A patent/CA2057747C/en not_active Expired - Fee Related
- 1991-12-17 CN CN91107996A patent/CN1036833C/zh not_active Expired - Fee Related
- 1991-12-17 JP JP3333718A patent/JPH04290830A/ja active Pending
1994
- 1994-01-14 US US08/182,304 patent/US5418228A/en not_active Expired - Lifetime
1996
- 1996-06-07 GR GR960401543T patent/GR3020181T3/el unknown

Also Published As

Publication number	Publication date
DE69118494D1 (de)	1996-05-09
KR920011515A (ko)	1992-07-24
ZA919770B (en)	1992-09-30
NZ240970A (en)	1994-05-26
AU8967991A (en)	1992-06-18
FI98985C (fi)	1997-09-25
DK0491438T3 (da)	1996-07-08
CA2057747C (en)	2003-07-29
JPH04290830A (ja)	1992-10-15
FI915914A7 (fi)	1992-06-18
KR100186780B1 (ko)	1999-05-01
NO914969L (no)	1992-06-18
US5418228A (en)	1995-05-23
IE914272A1 (en)	1992-06-17
PT99819A (pt)	1992-12-31
PT99819B (pt)	2001-05-31
NO914969D0 (no)	1991-12-16
ES2087965T3 (es)	1996-08-01
CN1036833C (zh)	1997-12-31
EP0491438A1 (de)	1992-06-24
FI915914A0 (fi)	1991-12-16
IE62665B1 (en)	1995-02-22
EP0491438B1 (de)	1996-04-03
CA2057747A1 (en)	1992-06-18
NO179311B (no)	1996-06-10
CN1062464A (zh)	1992-07-08
GR3020181T3 (en)	1996-09-30
NO179311C (no)	1996-09-18
AU645637B2 (en)	1994-01-20
DE69118494T2 (de)	1996-08-22
FI98985B (fi)	1997-06-13

Legal Events

Date	Code	Title	Description
1996-09-15	UEP	Publication of translation of european patent specification
2007-09-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
AU645637B2 (en)	1994-01-20	Contraceptive regimen
AU645382B2 (en)	1994-01-13	Low estrogen oral contraceptives
DK365887D0 (da)	1987-07-14	Kombinationsdoseringsform til hormonbehandling af kvinder i prae-menopausen
CY1105276T1 (el)	2010-03-03	Τριφασικο στοματικο αντισυλληπτικο
BR9710566A (pt)	1999-08-17	M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio
WO1998004246A3 (en)	2002-09-26	Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
NZ333862A (en)	2000-08-25	Triphasic oral contraceptive method and kit comprising a combination of progestin and estrogen
ATE249222T1 (de)	2003-09-15	Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten